Certara, Inc. $CERT Shares Sold by Kopion Asset Management LLC

Kopion Asset Management LLC decreased its holdings in shares of Certara, Inc. (NASDAQ:CERT) by 17.6% in the third quarter, Holdings Channel reports. The firm owned 1,532,364 shares of the company’s stock after selling 326,175 shares during the quarter. Certara comprises about 9.3% of Kopion Asset Management LLC’s portfolio, making the stock its 2nd biggest holding. Kopion Asset Management LLC’s holdings in Certara were worth $14,098,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in CERT. Integrated Wealth Concepts LLC bought a new stake in shares of Certara in the 2nd quarter valued at approximately $39,000. GAMMA Investing LLC lifted its position in shares of Certara by 21.2% during the 3rd quarter. GAMMA Investing LLC now owns 9,778 shares of the company’s stock worth $90,000 after buying an additional 1,710 shares during the period. NorthRock Partners LLC bought a new position in shares of Certara during the 2nd quarter worth approximately $68,000. State of Wyoming acquired a new stake in Certara in the 2nd quarter valued at $72,000. Finally, Perigon Wealth Management LLC acquired a new stake in Certara in the 2nd quarter valued at $80,000. 73.96% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have issued reports on CERT shares. UBS Group reiterated a “neutral” rating and set a $10.00 price objective on shares of Certara in a research note on Wednesday, September 30th. Barclays boosted their target price on shares of Certara from $7.50 to $9.00 and gave the company an “equal weight” rating in a research note on Wednesday. Finally, Weiss Ratings raised shares of Certara from a “sell (e+)” rating to a “sell (d)” rating in a report on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $8.60.

Certara Price Performance

Shares of Certara stock traded up $0.49 during trading on Friday, reaching $9.13. The company’s stock had a trading volume of 2,248,990 shares, compared to its average volume of 3,505,223. The stock has a 50-day moving average price of $8.38 and a two-hundred day moving average price of $6.84. The stock has a market capitalization of $1.39 billion, a P/E ratio of -20.30 and a beta of 1.42. The company has a current ratio of 2.55, a quick ratio of 2.55 and a debt-to-equity ratio of 0.30. Certara, Inc. has a one year low of $4.45 and a one year high of $13.11.

Certara (NASDAQ:CERT) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.01). Certara had a negative net margin of 16.75% and a positive return on equity of 3.86%. The company had revenue of $93.27 million during the quarter, compared to analyst estimates of $98.09 million. During the same quarter in the previous year, the business posted $0.07 EPS. The company’s revenue was down 10.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that Certara, Inc. will post 0.22 EPS for the current fiscal year.

Certara Profile

Certara, Inc (NASDAQ:CERT) provides software and technology-enabled services for the biopharmaceutical industry. The company helps drug developers use regulatory science, data analysis, and modeling and simulation to support decisions throughout the research, development, and commercialization lifecycle.

Its offerings include software for pharmacokinetic and pharmacodynamic modeling, clinical trial design, patient and disease modeling, regulatory submissions, and real-world data analysis.